VC firm
Epidarex Capital
Also known as EPIDAREX CAPITAL III US, EPIDAREX CAPITAL III US, LP
- Investor type
- VC
- Investing status
- Activeas of 2026-09-18Source (opens in a new tab)
- Headquarters
- BETHESDA, MD, United States
- Assets under management
- $16.9MForm ADV private fund GAV, as of 2026-03-27Source (opens in a new tab)
- Latest fund size
- $15.9MForm ADV gross asset value, as of 2019Source (opens in a new tab)
- Funds
- 4
- Legal name
- EPIDAREX CAPITAL MANAGEMENT LLC
Claim, correct or request removal
Record updated 29 September 2026
About
EPIDAREX IS A TRANSATLANTIC VENTURE CAPITAL FIRM LED BY A DIVERSE TEAM OF EARLY-STAGE INVESTORS BUILDING BREAKTHROUGH LIFE SCIENCE COMPANIES IN EMERGING HUBS
Investment approach
- Thesis
- We invest in early-stage, high-growth companies developing technologies with outstanding prospects for today’s global healthcare market.Source (opens in a new tab)
Funds
- EPIDAREX CAPITAL III US, LP
- Vintage 2019Main fund
- EPIDAREX CAPITAL IV, LP
- Main fund
- EPIDAREX II SPV, LP
- SPV
- EPIDAREX CAPITAL I, LP
- Main fund
SEC registration
- Registered adviser
- EPIDAREX CAPITAL MANAGEMENT LLC
- CRD number
- 307874 (opens in a new tab)
- SEC file number
- 802-118468
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $16.9Mas of 2026-03-27
- Private funds reported
- 3
- Principal office
- BETHESDA, MD, United States
- SEC CIK
- 1796711
Locations
- Office
- Edinburgh, United Kingdom
- Office
- Bethesda, Maryland, United States
Loading relationship preview